SG30591G - Use of azelastin and glycerine ethers for the treatment of psoriasis - Google Patents

Use of azelastin and glycerine ethers for the treatment of psoriasis

Info

Publication number
SG30591G
SG30591G SG1995905105A SG1995905105A SG30591G SG 30591 G SG30591 G SG 30591G SG 1995905105 A SG1995905105 A SG 1995905105A SG 1995905105 A SG1995905105 A SG 1995905105A SG 30591 G SG30591 G SG 30591G
Authority
SG
Singapore
Prior art keywords
treatment
azelastin
psoriasis
glycerine ethers
glycerine
Prior art date
Application number
SG1995905105A
Other languages
English (en)
Inventor
Juergen Dr Engel
Michael Dr Molliere
Istvan Dr Szelenyi
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of SG30591G publication Critical patent/SG30591G/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • E—FIXED CONSTRUCTIONS
    • E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
    • E02F—DREDGING; SOIL-SHIFTING
    • E02F3/00—Dredgers; Soil-shifting machines
    • E02F3/04—Dredgers; Soil-shifting machines mechanically-driven
    • E02F3/18—Dredgers; Soil-shifting machines mechanically-driven with digging wheels turning round an axis, e.g. bucket-type wheels
    • E02F3/20—Dredgers; Soil-shifting machines mechanically-driven with digging wheels turning round an axis, e.g. bucket-type wheels with tools that only loosen the material, i.e. mill-type wheels
    • E02F3/205—Dredgers; Soil-shifting machines mechanically-driven with digging wheels turning round an axis, e.g. bucket-type wheels with tools that only loosen the material, i.e. mill-type wheels with a pair of digging wheels, e.g. slotting machines
    • E—FIXED CONSTRUCTIONS
    • E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
    • E02F—DREDGING; SOIL-SHIFTING
    • E02F3/00—Dredgers; Soil-shifting machines
    • E02F3/04—Dredgers; Soil-shifting machines mechanically-driven
    • E02F3/88—Dredgers; Soil-shifting machines mechanically-driven with arrangements acting by a sucking or forcing effect, e.g. suction dredgers
    • E02F3/90—Component parts, e.g. arrangement or adaptation of pumps
    • E—FIXED CONSTRUCTIONS
    • E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
    • E02F—DREDGING; SOIL-SHIFTING
    • E02F3/00—Dredgers; Soil-shifting machines
    • E02F3/04—Dredgers; Soil-shifting machines mechanically-driven
    • E02F3/88—Dredgers; Soil-shifting machines mechanically-driven with arrangements acting by a sucking or forcing effect, e.g. suction dredgers
    • E02F3/90—Component parts, e.g. arrangement or adaptation of pumps
    • E02F3/92—Digging elements, e.g. suction heads
    • E02F3/9212—Mechanical digging means, e.g. suction wheels, i.e. wheel with a suction inlet attached behind the wheel
SG1995905105A 1989-01-11 1990-01-03 Use of azelastin and glycerine ethers for the treatment of psoriasis SG30591G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3900607 1989-01-11

Publications (1)

Publication Number Publication Date
SG30591G true SG30591G (en) 1995-09-18

Family

ID=6371863

Family Applications (2)

Application Number Title Priority Date Filing Date
SG1995905105A SG30591G (en) 1989-01-11 1990-01-03 Use of azelastin and glycerine ethers for the treatment of psoriasis
SG1995905121A SG30593G (en) 1989-01-11 1990-01-03 Use of the agent azelastine in the treatment of psoriasis

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG1995905121A SG30593G (en) 1989-01-11 1990-01-03 Use of the agent azelastine in the treatment of psoriasis

Country Status (15)

Country Link
US (1) US5110814A (es)
EP (2) EP0378086B1 (es)
JP (1) JP2991733B2 (es)
AT (2) ATE111735T1 (es)
AU (1) AU618443B2 (es)
CA (1) CA2007480C (es)
DE (3) DE4000070A1 (es)
DK (2) DK0533213T3 (es)
EG (1) EG19912A (es)
ES (2) ES2061307T3 (es)
HK (2) HK50595A (es)
IE (1) IE65336B1 (es)
MC (1) MC2078A1 (es)
PT (1) PT92821B (es)
SG (2) SG30591G (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3190441B2 (ja) * 1992-07-20 2001-07-23 エーザイ株式会社 塩酸アゼラスチンを含有する安定な製剤
NL9201438A (nl) * 1992-08-11 1994-03-01 Prospa Bv Nieuwe farmaceutische samenstellingen die esters van omega-3 polyonverzadigde zuren omvatten en de toepassing ervan bij de plaatselijke behandeling van ziekelijke aandoeningen.
CZ199593A3 (en) * 1992-10-02 1994-04-13 Asta Medica Ag Phthalazinone derivatives exhibiting anti-arrhythmic and analgesic activity and eliminating resistance to a plurality of medicaments (mdr)
US5569680A (en) * 1995-02-13 1996-10-29 Trustees Of The Univ. Of Penna Method of treating inflammatory bowel disease with tributyrin
JP4138910B2 (ja) * 1997-07-02 2008-08-27 帝國製薬株式会社 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤
US6984667B2 (en) * 1998-04-08 2006-01-10 Theta Biomedical Consulting And Development Co. Synergistic proteoglycan compositions for inflammatory conditions
DE19826517B4 (de) * 1998-06-15 2006-03-23 Baxter Healthcare S.A. Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette
DE10028638A1 (de) 2000-06-09 2001-12-20 Schuelke & Mayr Gmbh Lagerstabile Zusammensetzungen von Glycerinmonoalkylethern
CA2543689A1 (en) * 2003-10-31 2005-05-12 Hexal Ag Pharmaceutical actve-ingredient-containing formulation with coating
WO2005077963A1 (fr) * 2004-01-16 2005-08-25 Institut Superieur Agricole De Beauvais DErivEs de saccharides et d'itols possEdant un groupement O-alkyle ou un groupement O-alkyle et un groupement O-n-butanoyle. Applications comme mEdicaments dans les pathologies prolifEratives tumorales ou bEnignes.
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
SI2486942T1 (sl) 2004-11-24 2019-03-29 Meda Pharmaceuticals Inc. Sestavki, ki obsegajo azelastin, in postopki za njihovo uporabo
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
WO2014160440A1 (en) 2013-03-13 2014-10-02 Flatley Discovery Lab Pyridazinone compounds and methods for the treatment of cystic fibrosis
US10835584B2 (en) * 2016-06-17 2020-11-17 Nuvothera, Inc. Systems for treating dermal inflammatory conditions
US11318144B2 (en) 2019-04-12 2022-05-03 LA PharmaTech Inc. Compositions and methods for treating Alzheimer's disease and Parkinson's disease
US10966989B2 (en) 2019-04-12 2021-04-06 LA PharmaTech Inc. Pharmaceutical compositions and methods for treating mental, behavioral, cognitive disorders
US11938139B2 (en) * 2019-04-12 2024-03-26 LA PharmaTech Inc. Pharmaceutical compositions and methods for anxiety, depression and other psychiatric disorders
US11744833B2 (en) 2019-04-12 2023-09-05 LA PharmaTech Inc. Pharmaceutical compositions and methods for treatment of insomnia
US11690849B2 (en) 2019-04-12 2023-07-04 LA PharmaTech Inc. Method of treating dementia
US11389458B2 (en) 2019-04-12 2022-07-19 LA PharmaTech Inc. Pharmaceutical compositions and methods for treating parkinson's and huntington's disease
US10639314B1 (en) 2019-04-30 2020-05-05 LA PharmaTech Inc. Method of treating Alzheimer's disease
US11351179B1 (en) 2021-08-05 2022-06-07 LA PharmaTech Inc. Pharmaceutical compositions and methods for treatment of psychiatric disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3840606A (en) * 1969-12-05 1974-10-08 Oreal Process of producing mono and polyhydroxyl ethers
CH572914A5 (es) * 1971-01-22 1976-02-27 Asta Werke Ag Chem Fab
DE3343530A1 (de) * 1983-12-01 1985-06-13 Max Planck Gesellschaft Arzneimittel mit verbesserter penetration der gewebsmembran
US4871733A (en) * 1984-04-09 1989-10-03 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs

Also Published As

Publication number Publication date
DE59007531D1 (de) 1994-12-01
CA2007480A1 (en) 1990-07-17
US5110814A (en) 1992-05-05
PT92821B (pt) 1995-12-29
DE59007288D1 (de) 1994-10-27
CA2007480C (en) 1995-08-15
SG30593G (en) 1995-09-18
ES2063841T3 (es) 1995-01-16
HK50595A (en) 1995-04-13
JPH02288827A (ja) 1990-11-28
AU4786290A (en) 1990-07-19
ATE113208T1 (de) 1994-11-15
MC2078A1 (fr) 1991-01-07
DK0533213T3 (da) 1994-10-17
HK50495A (en) 1995-04-13
EP0378086B1 (de) 1994-10-26
IE65336B1 (en) 1995-10-18
EP0378086A3 (de) 1991-02-06
ATE111735T1 (de) 1994-10-15
DK0378086T3 (da) 1994-12-12
EP0533213B1 (de) 1994-09-21
IE900098L (en) 1990-07-11
AU618443B2 (en) 1991-12-19
DE4000070A1 (de) 1990-07-12
EP0533213A1 (de) 1993-03-24
PT92821A (pt) 1990-07-31
EG19912A (en) 1996-05-31
JP2991733B2 (ja) 1999-12-20
ES2061307T3 (es) 1994-12-01
EP0378086A2 (de) 1990-07-18

Similar Documents

Publication Publication Date Title
SG30591G (en) Use of azelastin and glycerine ethers for the treatment of psoriasis
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
NO157020C (no) AnalogifremgangsmŸte ved fremstilling av terapeutisk aktive 3,20-dioxo-1,4-pregnadien-17alfa-ol-17-aromatiske heterocykliske carboxylater.
IT8848491A0 (it) Impiego in terapeutica di derivati del 4h-benzo-4,5-cicloepta-1,2-bqti ofene
ZA889699B (en) Use of polysulfated heparins
DK317285D0 (da) Farmakologisk virksomme (pyrrol-1-yl)-phenyl-dihydropyridazinoner ogfremgangsmaade til fremstilling heraf
NO922136L (no) Anvendelse av gibberelliner for behandling av prostatitisog psoriasis
IT1167053B (it) Composti eterociclici terapeuticamente pregevoli nella cura di malattie autoimmuni
IT1092132B (it) Vite autofilettante nonche' procedimento per la sua fabbricazione e ganascia di cilindratura per l'attuazione del procedimento
ES2037053T3 (es) Derivados del acido (met)-acrilico de triisocianatos y su empleo.
IT1124398B (it) Utilizzazione della forma farmaceutica gel contenente acido 23 benzoilfenil propionico impiegabile in terapia per uso topico
ES2061722T3 (es) Derivados de fenantridina, procedimiento para su obtencion y agentes para la realizacion del procedimiento.
GR77250B (es)
IT1102304B (it) Composizione farmaceutica per la cura della sordita' e del ronzio auricolare
IT8448370A0 (it) Citrato trisodico utilizzabile nella cura delle malattie artriticoreumatiche
IT7868550A0 (it) Derivati del pacetamnidofenoloprocedimentp per la loro preparazione e loro impiego terapeutico
IT7886233A0 (it) Stampelle ginniche con sottoascella ri molleggiati,atte alla cura di disturbi miostonici ed artrosici
IT1221681B (it) Procedimento di inertizzazione (riduzione) dei composti del cromo e savalente,presenti nei laterizi
IT1166217B (it) Composizione farmaceutica per la terapia delle sterilita' maschile
IT8741690A0 (it) Farmaco per la profilassi e per la cura delle disbatteriosi vaginali.
IT8721591A0 (it) Protesi per il pene in particolareper incrementare il diametro del pene.
BE864975A (fr) Composition pour la prophylaxie et le therapeutique de l'acne vulgaris
ES260825Y (es) Un dispositivo de protesis definitivo o transitorio para sosten del torax
IT1157317B (it) Procedimento atto ad incrementare la solubilita' in acqua del naprozene morfulina